Roche’s Genentech invests $2 billion in first East Coast manufacturing plant in North Carolina
Roche and Genentech to build North Carolina manufacturing site
Roche will invest about USD 2 billion to build Genentech’s first East Coast manufacturing site in Holly Springs, North Carolina.
- The project reached a topping-out milestone with the final structural beam placed, keeping construction on schedule.
- The site will manufacture next-generation metabolic medicines, including obesity treatments, using automation, robotics, digital manufacturing, and an AI-powered digital twin.
- The facility is expected to support over 2,000 jobs, including more than 500 manufacturing roles.
- The investment forms part of Roche and Genentech’s USD 50 billion U.S. R&D and manufacturing infrastructure commitment.
Related News
Darling Ingredients EVP Chief Strategy Officer Sandra Dudley disposes of common shares worth $666,180.54
DAR•
Catheter Precision’s Flyte partners with FullPAC to target political campaign travel market
VTAK•
